Boosting Oncolytic Adenovirus Potency with Magnetic Nanoparticles and Magnetic Force
Mice, Inbred BALB C
0303 health sciences
Mice, Nude
Xenograft Model Antitumor Assays
Adenoviridae
3. Good health
Pancreatic Neoplasms
Blotting, Southern
Magnetics
Mice
Oncolytic Viruses
03 medical and health sciences
Microscopy, Electron, Transmission
Drug Resistance, Neoplasm
Cell Line, Tumor
Animals
Humans
Nanoparticles
Female
DOI:
10.1021/mp100123t
Publication Date:
2010-06-15T16:40:46Z
AUTHORS (10)
ABSTRACT
Oncolytic adenoviruses rank among the most promising innovative agents in cancer therapy. We examined potential of boosting efficacy oncolytic adenovirus dl520 by associating it with magnetic nanoparticles and magnetic-field-guided infection multidrug-resistant (MDR) cells vitro upon intratumoral injection vivo. The virus was complexed self-assembly core−shell having a magnetite core about 10 nm stabilized shell containing 68 mass % lithium 3-[2-(perfluoroalkyl)ethylthio]propionate) 32 25 kDa branched polyethylenimine. Optimized binding, sufficiently stable 50% fetal calf serum, found at nanoparticle-to-virus ratios 5 fg Fe per physical particle (VP) above. As estimated from magnetophoretic mobility measurements, 3,600 to 4,500 nanocrystallites were associated particle. Ultrastructural analysis electron atomic force microscopy showed structurally intact viruses surrounded particles that occasionally bridged several particles. Viral uptake into given dose enhanced 10-fold compared nonmagnetic when infections carried out under influence field. Increased internalization resulted enhancement potency terms required for killing target (IC50 value) an 4 orders magnitude progeny formation equal input doses viruses. Furthermore, full effect developed within two days postinfection six as reference. Plotting cell viability versus internalized inherent productivity remained unchanged association nanoparticles. Hence, we conclude mechanism is mainly due improved complexes resulting potentiated formation. Upon application gradient field murine xenograft model, exhibited stronger than alone. propose this approach would be useful during vivo administration tumor-feeding blood vessels boost primary cycle tumor. For systemic application, further modification shielding retargeting whole complex entity needed.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (76)
CITATIONS (52)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....